MYLAN 2264 MYLAN 2264 (Terazosin Hydrochloride 2 mg)
Pill with imprint MYLAN 2264 MYLAN 2264 is Black / Purple, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Mylan Pharmaceuticals Inc..
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 2264 MYLAN 2264
Terazosin Hydrochloride
- Imprint
- MYLAN 2264 MYLAN 2264
- Strength
- 2 mg
- Color
- Black / Purple
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
D&C Red No. 28,
D&C Red No. 33,
FD&C Blue No. 1,
magnesium stearate,
microcrystalline cellulose,
corn starch,
sodium lauryl sulfate,
titanium dioxide,
ferrosoferric oxide,
ammonia,
propylene glycol,
shellac,
dimethicone
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-2264 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0937 (Discontinued) | UDL Laboratories Inc. |
More about terazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 43 Reviews
- Drug class: antiadrenergic agents, peripherally acting
Patient resources
- Other brands
- Hytrin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.